April 23, 2013
On April 10, 2013, the United States Sentencing Commission promulgated its annual amendments to the federal sentencing guidelines. Reacting to congressional directives, the Commission voted to increase penalties for (1) theft and fraud involving pre-retail medical products, (2) trafficking in counterfeit drugs and military equipment, and (3) foreign dissemination of stolen trade secrets. The Commission also made an important change that will reduce sentences for tax offenses. A current rule in several federal circuits frequently causes "tax loss" to be overstated for sentencing purposes because it directs courts to look solely at the amount of undeclared income to determine the tax impact of an offense. The amendment will require courts also to consider the other side of the ledger: related deductions, exemptions, or credits that could have been included on a lawfully filed tax return, thus reducing the tax that was owed.
The Commission also voted to resolve a conflict in the federal courts of appeals involving the guideline that reduces sentences for defendants who plead guilty early enough to spare the government the expenditure of time and resources needed to prepare for trial.
The newly adopted amendments will take effect November 1, 2013, unless Congress modifies them through legislation.
Calculating Tax Loss — Defendants Can Seek Credit for Unclaimed Deductions
In a victory for defendants in tax prosecutions, the Commission voted to amend the guideline applicable to most tax offenses (§2T1.1) to address a circuit conflict on calculating tax loss. In the Second and Tenth Circuits, a defendant has been allowed to present evidence of deductions that could have been lawfully claimed had the defendant filed a correct return. But six others–the Fourth, Fifth, Seventh, Eighth, Ninth, and Eleventh Circuits–have not allowed such proof. In January of this year, the Commission proposed three different options for resolving this conflict: presumptively allowing consideration of unclaimed deductions, categorically prohibiting their consideration, or presumptively prohibiting calculations based on unclaimed deductions unless the defendant demonstrates through contemporaneous documentation that he or she would have claimed them. During the public comment period, the criminal defense bar supported the most permissive option, while the Department of Justice’s Tax Division urged the Commission to categorically prohibit consideration of unclaimed deductions.
The views of the defense community largely prevailed. The Commission decided to add an application note to the Tax Guideline directing sentencing courts to account for any unclaimed deduction that is "needed to ensure a reasonable estimate of the tax loss" if such deduction "was related to the tax offense and could have been claimed at the time the tax offense was committed," is "reasonably and practicably ascertainable," and is supported by sufficiently reliable information. The Commission decided, however, to exclude from consideration "payments to third parties made in a manner that encouraged or facilitated a separate violation of law," such as bribes to public officials or "under the table" payments to employees. Finally, the defendant will bear the burden of establishing that an unclaimed deduction was available.
This amendment will permit a more accurate measurement of the consequences to the federal fisc from a false return, without turning federal sentencing proceedings into de facto IRS audits. For example, a business owner who fails to report cash revenue on his return will now be allowed to show that portions of that revenue were used to pay deductible operating expenses. Consideration of both expenses and income will better reflect the true economic impact of tax offenses. At the same time, the amendment will continue to prohibit consideration of unclaimed deductions that–because unclaimed–encouraged additional violations of law (like "under the table" payments to employees that allowed the employees to evade their own taxes).
Increased Penalties for Economic Offenses
Theft of Pre-Retail Medical Products
In the SAFE DOSES Act, Pub. L. 112-186 (October 5, 2012), Congress created a new criminal offense for theft of pre-retail medical products, harmonized the penalties for pre-existing statutory offenses when a pre-retail medical product is involved in the offense, and directed the Commission to "review and, if appropriate, amend" the various sentencing guidelines and policy statements applicable to the new and related offenses.
In response, the Commission referenced this new statutory offense to the existing economic crimes guideline (§2B1.1). Unfortunately, the Commission also added a new specific offense characteristic to §2B1.1, a guideline already plagued by a multitude of redundant, overlapping enhancements that overstate offense seriousness. The new enhancement provides a two-level increase for any offense under the new law (18 U.S.C. § 670), and a four-level increase if the defendant was employed by, or an agent of, an organization in the supply chain for the pre-retail product. The term "supply chain" includes any manufacturer, wholesaler, repacker, own-labeled distributor, private-label distributor, jobber, broker, drug trader, transportation company, hospital, pharmacy, or security company involved in the creation, sale, or distribution of the medical product before it is made available for retail purchase by a consumer.
The Act’s legislative history indicates that Congress intended to target sophisticated criminal organizations that steal and traffic in large quantities of medical products. But the new two- and four-level enhancements threaten to reach far more ordinary fraud defendants. For example, a CVS truck driver who acquiesces in the theft of ice bags and toothbrushes from his vehicle will now be treated more severely than defendants whose theft or fraud offenses involved the same amount of dollar loss, including a similarly situated CVS in-store employee (or even a store manager) whose theft occurred "post-retail," e.g., after the same products were placed on the store’s shelf.
Trafficking In Counterfeit Goods and Services, and Adulterated Drug Offenses
The Commission also created new penalties for trafficking in counterfeit or adulterated drugs and counterfeit military equipment. Explaining the importance of these amendments, Judge Patti B. Saris, Chair of the Commission, noted that counterfeit drugs "can endanger public health and safety," and that counterfeit military equipment, which often originates outside the United States, "can undermine the military and place servicemen and women in harm’s way." The Commission added to the guideline for such offenses (§2B5.3) two new specific offense characteristics: a two-level enhancement for offenses involving a counterfeit drug, and a two-level enhancement (with a minimum offense level of 14) for offenses involving a counterfeit military good or service "the use, malfunction, or failure of which is likely to cause the disclosure of classified information; impairment of combat operations; or other significant harm to a combat operation, a member of the Armed Forces, or to national security." In a new application note, the Commission indicated that "other significant harm …" means significant harm other than bodily injury or death, which is already subject to two-level enhancement under the current §2B5.3(b)(5)(A).
The Commission also substantially increased punishment for adulterated drug offenses that "have a reasonable probability of causing serious adverse health consequences or death to humans or animals" by referencing such offenses to §2N1.1 and thereby increasing the "base" (or starting) offense level from 6 to 25. Defendants sentenced under this provision now face a base offense level equating to a recommended prison range of 57 to 71 months, higher than the base offense levels applicable to criminal sexual abuse of a minor or involuntary manslaughter.
International Theft of Trade Secrets and Economic Espionage
In response to Congress’s directive in the Foreign and Economic Espionage Penalty Enhancement Act of 2012, Pub. L. 112-269 (January 14, 2013), the Commission revised §2B1.1’s specific offense characteristic governing the misappropriation of trade secrets. Under current practice, a defendant who misappropriates a trade secret with the knowledge or intent that a foreign government, instrumentality, or agent would benefit receives a two-level enhancement. Under the Commission’s replacement provision (§2B1.1(b)(12)), such a defendant would now receive a four-level enhancement (with a minimum offense level of 14). The provision also creates a new two-level enhancement for misappropriation in which a trade secret is knowingly transported or transmitted out of the United States.
Acceptance of Responsibility — A Mixed Bag for Defendants
Finally, the Commission responded to two circuit conflicts involving the guideline for acceptance of responsibility (§3E1.1). A defendant who clearly demonstrates acceptance of responsibility for his offense receives a two-level reduction under subsection (a). The circuit conflicts both involve the circumstances under which the defendant is eligible for a third level of reduction under subsection (b), which is available only after a government motion stating that the defendant has offered assistance by "timely notifying authorities of his intention to enter a plea of guilty, thereby permitting the government to avoid preparing for trial and permitting the government and the court to allocate their resources efficiently." Circuits have disagreed over (1) whether the sentencing court has discretion to deny the third level of reduction when the government has filed a motion and the defendant is otherwise eligible, and (2) whether the government has discretion to withhold a motion based on whether the defendant agrees to waive his or her right to appeal.
Regarding the first conflict, the Commission amended the guideline’s application note to state that the sentencing court has discretion to deny reduction by the third level. The Commission added, however, that a court may not add new requirements as a basis to deny the motion. The court’s inquiry is the same: whether the defendant assisted authorities in the investigation or prosecution of his own misconduct by timely notifying authorities of his intention to enter a plea of guilty, thereby permitting the government to avoid preparing for trial and permitting the government and the court to allocate their resources efficiently. In a similar vein, the Commission resolved the other conflict by adding that the government "should not" withhold filing a motion for the third level of acceptance reduction based on interests other than those related to the timeliness of the defendant’s plea, such as whether the defendant has agreed to waive his or her right to appeal.
The end result of the amended application note will be to cabin both the sentencing court’s and the government’s discretion to those efficiency gains realized as result of the timeliness of the defendant’s plea, such as the government’s avoidance of the need to prepare for trial. The government will remain free to negotiate for appeal waivers in plea negotiations, but it can no longer threaten to withhold a §3E1.1(b) motion as leverage for extracting waivers of those or other constitutional and statutory rights.
Conclusion — Awaiting Comprehensive Reform
The Commission has stated that its multi-year comprehensive review of the much-criticized economic crimes guideline is underway. The outcome of that review–which may be announced in 2014–could be dramatic. In the meantime, the Commission’s 2013 amendments are more targeted in scope by focusing largely on specific theft and fraud offenses that have been the subject of Congress’s recent attention. With the significant exception of the Commission’s clarification regarding tax-loss calculation, most of these amendments threaten even greater penalties for theft and fraud offenses.
The attorneys at Gibson Dunn have been extensively involved in the Guidelines amendment process. They include David Debold in the Washington, D.C. office (202-955-8551, email@example.com), who chairs the Commission’s Practitioners Advisory Group and testified at the Commission’s public hearing on guidelines amendments, and Matthew Benjamin in the firm’s New York office (212-351-4079, firstname.lastname@example.org), who is also a PAG member. In addition, Gibson Dunn’s White Collar Defense and Investigations Practice Group has vast experience defending against a wide range of federal and state prosecutions in a variety of areas. For more information on the firm’s white collar defense practice, please contact any member of the group.
F. Joseph Warin (202-887-3609, email@example.com)
David P. Burns (202-887-3786, firstname.lastname@example.org)
David Debold (202-955-8551, email@example.com)
Michael S. Diamant (202-887-3604, firstname.lastname@example.org)
Miguel A. Estrada (202-955-8500, email@example.com)
John H. Sturc (202-955-8243, firstname.lastname@example.org)
Jim Walden (212-351-2300, email@example.com)
Joel M. Cohen (212-351-2664, firstname.lastname@example.org)
Lee G. Dunst (212-351-3824, email@example.com)
Mark A. Kirsch (212-351-2662, firstname.lastname@example.org)
Orin Snyder (212-351-2400, email@example.com)
Alexander H. Southwell (212-351-3981, firstname.lastname@example.org)
Lawrence J. Zweifach (212-351-2625, email@example.com)
Debra Wong Yang (213-229-7472, firstname.lastname@example.org)
Michael M. Farhang (213-229-7005, email@example.com)
Douglas M. Fuchs (213-229-7605, firstname.lastname@example.org)
Marcellus A. McRae (213-229-7675, email@example.com)
Rachel S. Brass (415-393-8293, firstname.lastname@example.org)
Winston Y. Chan (415-393-8362, email@example.com)
Gary R. Spratling (415-393-8222, firstname.lastname@example.org)
Michael Li-Ming Wong (415-393-8234, email@example.com)
Benoît Fleury (+33 1 56 43 13 00, firstname.lastname@example.org)
Bernard Grinspan (+33 1 56 43 13 00, email@example.com)
Jean-Philippe Robé (+33 1 56 43 13 00, firstname.lastname@example.org)
Audrey Obadia-Zerbib (+33 1 56 43 13 00, email@example.com)
© 2013 Gibson, Dunn & Crutcher LLP
Attorney Advertising: The enclosed materials have been prepared for general informational purposes only and are not intended as legal advice.